Health: FDA News

Today is June 20, 2024. All times in Eastern Daylight Time.

Cessation Therapeutics Announces Oral Presentation of Preliminary Findings from First-in-Human Study of Anti-Fentanyl Monoclonal Antibody, CSX-1004

06/19/2024 - 11:30 AM

BUSINESS WIRE
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001

06/19/2024 - 08:00 AM

BUSINESS WIRE
Empatica anuncia la integración de Mobilise-D Mobility Outcomes y avanza hacia una solución unificada para los profesionales clínicos

06/18/2024 - 06:11 PM

BUSINESS WIRE
Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game

06/18/2024 - 04:01 PM

BUSINESS WIRE
Empatica kondigt de integratie aan van Mobilise-D Mobility Outcomes, op weg naar een uniforme oplossing voor klinische professionals

06/18/2024 - 03:32 PM

BUSINESS WIRE
Empatica annuncia l'integrazione dei risultati di mobilità di Mobilise-D, promuovendo una soluzione unificata per i professionisti clinici

06/18/2024 - 03:31 PM

BUSINESS WIRE
Empatica kündigt die Integration von Mobilise-D Mobility Outcomes an und geht damit einen Schritt weiter in Richtung einer einheitlichen Lösung für klinische Fachkräfte

06/18/2024 - 03:31 PM

BUSINESS WIRE
Empatica annonce l’intégration des résultats de mobilité de Mobilise-D et pose les bases d’une solution unifiée pour les professionnels cliniques

06/18/2024 - 03:31 PM

BUSINESS WIRE
Neurogene Announces First Patient Dosed in High-Dose Cohort of NGN-401 Gene Therapy Clinical Trial for Rett Syndrome

06/18/2024 - 09:26 AM

BUSINESS WIRE
IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets

06/18/2024 - 09:00 AM

BUSINESS WIRE
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award

06/18/2024 - 08:17 AM

BUSINESS WIRE
Empatica Announces Integration of Mobilise-D Mobility Outcomes, Advancing Toward Unified Solution for Clinical Professionals

06/18/2024 - 08:04 AM

BUSINESS WIRE
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults

06/18/2024 - 08:00 AM

BUSINESS WIRE
PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team

06/18/2024 - 07:05 AM

BUSINESS WIRE
Elixir Medical’s DynamX Sirolimus-Eluting Coronary Bioadaptor System Granted FDA Breakthrough Device Designation for the Treatment of Symptomatic Ischemic Heart Disease

06/18/2024 - 07:00 AM

BUSINESS WIRE
KalVista Submits New Drug Application to FDA for Sebetralstat as First Oral On-demand Treatment for Hereditary Angioedema

06/18/2024 - 06:30 AM

BUSINESS WIRE
INVIZA® Health Awarded $2.3 M SEMI NBMC – U.S. Air Force Contract to Revolutionize Military and Medical Monitoring with Cutting-Edge Machine Learning Capabilities

06/18/2024 - 02:00 AM

BUSINESS WIRE
U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

06/17/2024 - 05:29 PM

BUSINESS WIRE
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma

06/17/2024 - 05:15 PM

BUSINESS WIRE
Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™ (vigabatrin) as the First and Only Ready-to-Use Vigabatrin Oral Solution

06/17/2024 - 04:00 PM

BUSINESS WIRE
SpineThera, Inc. to Collaborate With Mayo Clinic to Advance Solutions in Substance Abuse Disorder Treatment

06/17/2024 - 10:00 AM

BUSINESS WIRE
SiNAPTIC Technologies Receives Colorado State Grant to Advance Ceramic Additive Manufacturing Technology

06/17/2024 - 07:00 AM

BUSINESS WIRE
IMFINZI® (durvalumab) plus chemotherapy approved in the US for mismatch repair deficient advanced or recurrent endometrial cancer

06/17/2024 - 07:00 AM

BUSINESS WIRE
Marinus Pharmaceuticals Announces Topline Results from Phase 3 RAISE Trial of IV Ganaxolone in Refractory Status Epilepticus

06/17/2024 - 07:00 AM

BUSINESS WIRE
Element Announces RegNav, its First AI-Powered Platform Promoting Safer and More Reliable Medical Device Development

06/17/2024 - 06:01 AM

BUSINESS WIRE

1 2 3 4 5 6 7

Next »

Search